BR Biopharma (NASDAQ:BRBI) Shares Up 0.3% – Time to Buy?

Posted by Jessica Moore on Jul 26th, 2026

BR Biopharma, Inc. (NASDAQ:BRBI – Get Free Report)’s share price traded up 0.3% on Friday . The company traded as high as $11.45 and last traded at $11.4860. Approximately 541 shares traded hands during mid-day trading, a decline of 16% from the average session volume of 641 shares. The stock had previously closed at $11.45.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings raised shares of BR Biopharma from a “sell (e)” rating to a “sell (d-)” rating in a research note on Thursday, June 4th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.

Read Our Latest Report on BRBI

BR Biopharma Price Performance

The company’s 50-day moving average is $11.97.

BR Biopharma (NASDAQ:BRBI – Get Free Report) last announced its earnings results on Tuesday, March 31st. The company reported $0.09 earnings per share for the quarter. The business had revenue of $25.95 million for the quarter.

BR Biopharma Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, June 5th. Shareholders of record on Tuesday, May 19th were given a dividend of $0.147 per share. The ex-dividend date was Tuesday, May 19th. This represents a $0.59 dividend on an annualized basis and a yield of 5.1%.

Hedge Funds Weigh In On BR Biopharma

A hedge fund recently bought a new position in BR Biopharma stock. Acuitas Investments LLC bought a new position in shares of BR Biopharma, Inc. (NASDAQ:BRBI – Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 3,000 shares of the company’s stock, valued at approximately $45,000. BR Biopharma makes up approximately 3.2% of Acuitas Investments LLC’s investment portfolio, making the stock its 7th largest position.

BR Biopharma Company Profile

(Get Free Report)

BRBI BR Partners SA, through its subsidiaries, operates as an investment bank which specializes in providing financial services for entrepreneurs and families principally in Brazil. It offers financial advisory services for mergers and acquisitions, capital markets, board services, shareholders, special situations and restructuring, pre-IPO, and privatization; and wealth management services. BRBI BR Partners SA is based in S?o Paulo, Brazil.